Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study

Fertility and Sterility

Volumn 91, Issue 4 SUPPL., 2009, Pages 1441-1444

  Coosemans, An ^a   Moerman, Philippe ^b   Vergote, Ignace ^a   Koninckx, Philippe R ^a   Van Gool, Stefaan W ^b   Amant, Frédéric ^a  

^a Lab of Obstetrics and Gynaecology   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

WT1 PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNERVATION; NERVE CELL; PAIN; PRIORITY JOURNAL;

ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION; GENES, WILMS TUMOR; HUMANS; NERVE GROWTH FACTOR; NEURONS; PILOT PROJECTS; RECEPTOR, TRKA; S100 PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; WT1 PROTEINS;

EID: 63449098660     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.06.042     Document Type: Article

References (12)

1. Hohenstein P., and Hastie N.D. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 15 (2006) R196-R201
2. Moore A.W., McInnes L., Kreidberg J., Hastie N.D., and Schedl A. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126 (1999) 1845-1857
3. Nakatsuka S., Oji Y., Horiuchi T., Kanda T., Kitagawa M., Takeuchi T., et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 19 (2006) 804-814
4. Wagner K.D., Wagner N., Vidal V.P., Schley G., Wilhelm D., Schedl A., et al. The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J 21 (2002) 1398-1405
5. Wagner N., Wagner K.D., Hammes A., Kirschner K.M., Vidal V.P., Schedl A., et al. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system. Development 132 (2005) 1327-1336
6. Lovell M.A., Xie C., Xiong S., and Markesbery W.R. Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Brain Res 983 (2003) 84-96
7. Koninckx P.R., Meuleman C., Demeyere S., Lesaffre E., and Cornillie F.J. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 55 (1991) 759-765
8. Anaf V., Simon P., Nakadi I.E., Fayt I., Simonart T., Buxant F., et al. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod 17 (2002) 1895-1900
9. Sofroniew M.V., Howe C.L., and Mobley W.C. Nerve growth factor signalling, neuroprotection, and neural repair. Ann Rev Neurosci 24 (2001) 1217-1281
10. Liu X.W., Gong L.J., Guo L.Y., Katagiri Y., Jiang H., Wang Z.Y., et al. The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells. J Biol Chem 276 (2001) 5068-5073
11. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., and Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19 (1999) 2455-2463
12. Sobaniec-Lotowska M.E., Ciolkiewicz M., Pogumirski J., Sulkowski S., and Sobczak A. Morphometry of synaptophysin immunoreactive ganglion cells in Auerbach plexus in patients with colorectal cancer. Is this a new prognostic factor?. Folia Neuropathol 42 (2004) 167-170